Pharma Says Its Antidepressant Fails to Beat Placebo


Vanda Pharmaceuticals, Inc., announced this week that its new antidepressant Tasimelteon failed to beat placebo in trials, and that it has hence ended its program of trials for the drug.

Press Release →

Of further interest: Vanda Drug Fails in Depression Study (Motley Fool)

Previous articleAntidepressants Linked to Heart Arrhythmias
Next article“You Keep Giving Adderall to my Son, You’re Going to Kill Him”
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].